Recently, scientists have discovered a novel strain of Coronavirus (COVID-19) that is more deadly than SARS-CoV and MERS-CoV combined. This has caused a massive viral outbreak globally, and due to the lack of information about this strain, there are limited treatment options and research tools available. The World Health Organization (WHO) has declared a global health emergency to gather resources and remedy this threat.
Caltag Medsystems has access to Coronavirus research antibodies, proteins, kits and anti-viral agents. These research products can detect SARS-CoV, SARS, MERS Coronaviruses and other markers that may be linked to the virus. For more information or help sourcing a product please contact us
COVID-19 Background
There are four coronavirus genera: alphacoronavirus, betacoronavirus, gammacoronavirus, and deltacoronavirus. COVID-19 belongs to the Betacoronavirus genus originating from bats. Betacoronaviruses can infect mammals, are zoonotic pathogens, and can cause severe respiratory disease in humans.
Other viruses in this family are SARS coronavirus and MERS coronavirus. COVID-19V has approximately 79% sequence identity to SARS-CoV and 50% to MERS-CoV. In addition, homology modeling shows it has a similar receptor-binding domain structure as SARS-CoV which suggesting COVID-19 may use ACE2 as a receptor in humans for infection.
COVID-19 Products
- SARS Antibody
- SARS Spike
- SARS Matrix
- SARS Envelope
- ACE2 Antibody (SARS Receptor)
- SARS-CoV Antibody
- SARS-CoV Protein
- SARS-CoV Test/Detection Kit
Related COVID-19 Posts
- 2019-nCoV Antibodies from ProSci
- COVID-19/SARS-CoV-2 Detection Kits
- Screening for COVID-19 T-Cell Peptides and Immune Monitoring with MHC Tetramers In A Single Assay
- Interleukin-6 release in response to Coronavirus 19